5KW vs GS71: Side-by-Side Comparison
Compare SKINBIO THERAP LS-01 (5KW) and GSK plc (GS71) side by side: market cap EUR 32.14M vs EUR 91.51B. Financials, growth and model signals on Bullrun.
| Metric | 5KW | GS71 |
|---|---|---|
| Company | SKINBIO THERAP LS-01 | GSK plc |
| Country / Exchange | United Kingdom · F | United Kingdom · XETRA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - General |
| Market cap | EUR 32.14M | EUR 91.51B |
| P/E ratio | — | 13.8 |
| Dividend yield | — | 3.40% |
| Valuation model | — | 30.7% undervalued |
| Revenue (FY2025) | EUR 4.64M | GBP 32.67B |
| Revenue growth YoY | +283.7% | +4.1% |
| Net income | EUR -696.25K | GBP 6.29B |
| Gross margin | 61.6% | 72.4% |
| Diluted EPS | -0.00 | 1.39 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.